Infant GER: Inclined Positioning and Infant Gastroesophageal Reflux

Sponsor
Milton S. Hershey Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04542239
Collaborator
Iron Mountains (Other)
35
1
10.4
3.4

Study Details

Study Description

Brief Summary

The purpose of this voluntary research study is to evaluate the extent to which infants with Gastroesophageal Reflux (GER) exhibit oxygen desaturation (low oxygen levels in their blood) and bradycardia (slow heart rate) in supine (lying flat on back) and inclined positions.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Mothers will bring their infants to the Clinical Research Center where they will be escorted to a private room. Participants will proceed to feed their infant a typical liquid meal (i.e. breastmilk or formula). Within 15 minutes of completion of the feed, infants will be placed in the prototype infant reclining device at either 0, 10, 18, or 28 degrees of incline. Infants will spend 15 minutes at each level of incline in a randomly assigned order. During this time period that each infant is under observation the infant may be entertained/distracted/comforted with white noise, music or other forms of distraction as determined by the mother or study team. Mothers may touch/caress their infant or use a pacifier to soothe infant as needed so long as each 15 minute segment is completed. Following each 15 minute segment, a "washout" period will be used such that the next 15 minute segment will not begin for a minimum of 1 minute to a maximum of 5 minutes in duration before the next incline position is begun. This allows for a clean start and stop period for each 15 minute segment that is not impacted by either the prior position or the change to the new position. This also allows mothers or study staff to pick up and comfort the infant.

    During each of the four 15 minute segments, infants will be monitored using the Masimo RAD-97 pulse oximeter with data continuously collected regarding oxygen saturation and heart rate in 2-second intervals. The oxygen saturation probe will preferably be attached to a big toe, but can be placed in alternative spots consistent with usual clinical care such that a consistent reading of heart rate and oxygen saturation are recorded. A study coordinator will complete a data collection form for each segment characterizing whether GER occurred (spit-up into mouth or outside of mouth), the number of GER episodes as well as a subjective assessment of degree crying/fussing, hiccups, back arching, and breathing difficulty. The coordinator will also have a timer to measure the duration of crying in each position. Infants will be video recorded as a backup method for symptom assessment and for qualitative assessments by the study sponsor.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    35 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Inclined Positioning and Infant Gastroesophageal Reflux Indicators
    Actual Study Start Date :
    Mar 15, 2021
    Actual Primary Completion Date :
    Jan 25, 2022
    Actual Study Completion Date :
    Jan 25, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Infants with GER

    Infants (N=25) meeting inclusion/exclusion criteria

    Controls without GER

    Infants (N=10) meeting inclusion/exclusion criteria, but no GER

    Outcome Measures

    Primary Outcome Measures

    1. Number of hypoxic episodes [1 hour observation period]

      Evaluate the extent to which infants exhibit oxygen desaturation (oxygen saturation <94%) in each position

    2. Number of bradycardia episodes [1 hour observation period]

      Evaluate the extent to which infants exhibit bradycardia (heart rate <100 beats per minute) in each position

    3. Number of observed regurgitations [1 hour observation periods]

      Evaluate the extent to which infants exhibit clinical signs and symptoms of post-feed regurgitation in each position

    Secondary Outcome Measures

    1. Time spent in hypoxic episodes [1 hour observation period]

      Minutes spent in hypoxia in each position

    2. Time spent in bradycardic episodes [1 hour observation period]

      Minutes spent in bradycardia in each position

    3. Time spent fussing or crying [1 hour observation period]

      Minutes spent fussing or crying in each position

    4. Observed cyanosis episodes [1 hour observation period]

      Number of episodes of observed cyanosis (turning blue) in each position

    5. Subjective assessment of crying, hiccups, back arching, and respiratory distress [1 hour observation period]

      Yes/no answer in each position

    6. Subjective maternal perception of infant comfort in each position [1 hour observation period]

      very comfortable, comfortable, neither comfortable nor uncomfortable, uncomfortable, very uncomfortable

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 5 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • born at >= 34 weeks gestation

    • weight for age >= 10th percentile

    • No serious medical conditions

    • English-speaking parent capable of consenting

    • Diagnosis of GER from healthcare provider (not necessary for controls)

    • 4 or more visible spit-ups (mouth or nose) per day for at least 5 days OR 2 or more spit-ups out of the nose per day for at least 5 days OR I-GERQ score >=16 (not necessary for controls)

    • If applicable, parent willing to refrain from giving medication for GER for 12 hours prior to study participation

    Exclusion Criteria:
    • Signs of a more serious or complex illness including weight loss, lethargy, fever, excessive irritability/pain, bulging fontanelle, seizures, macro/microcephaly, bilious vomiting, hematemesis, chronic diarrhea, rectal bleeding, suspicions of GI obstruction

    • History of a Brief Resolved Unexplained Event (BRUE)

    • Use of a Home Apnea Monitor prescribed by a healthcare provider

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Penn State Milton S Hershey Medical Center Hershey Pennsylvania United States 17033

    Sponsors and Collaborators

    • Milton S. Hershey Medical Center
    • Iron Mountains

    Investigators

    • Principal Investigator: Ian M Paul, MD, Penn State College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ian M. Paul, MD, Professor of Pediatrics, Milton S. Hershey Medical Center
    ClinicalTrials.gov Identifier:
    NCT04542239
    Other Study ID Numbers:
    • HRP591
    First Posted:
    Sep 9, 2020
    Last Update Posted:
    Apr 29, 2022
    Last Verified:
    Apr 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 29, 2022